Perspective Therapeutics, Inc. Share Price
AMEX: CATX | Micro CapPerspective Therapeutics, Inc. Stock Performance
Perspective Therapeutics, Inc. Share Price Today
As of 29 October 2026, Perspective Therapeutics, Inc.'s share price is $1.21. The stock opened at $1.25, compared to its previous close of $1.21. During today's trading session, Perspective Therapeutics, Inc.'s share price traded between $1.20 and $1.27, with an average price of $1.23. Over the past 52 weeks, the stock has recorded a high of $6.16 and a low of $1.06. In terms of performance, Perspective Therapeutics, Inc.'s share price has declined by 69.10% over the last six months and is down 55.86% on a year-on-year basis.
Perspective Therapeutics, Inc. Share Price Chart
Perspective Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Perspective Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Perspective Therapeutics, Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Perspective Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.69 | $1.23 | -55.37% |
Sep 2026 | $3.16 | $2.75 | -13.41% |
Aug 2026 | $2.88 | $3.17 | +9.69% |
Jul 2026 | $3.43 | $2.89 | -15.12% |
Jun 2026 | $3.87 | $3.40 | -13.69% |
May 2026 | $3.90 | $3.94 | +1.15% |
Apr 2026 | $4.16 | $3.90 | -6.47% |
Mar 2026 | $5.12 | $4.17 | -22.63% |
Feb 2026 | $4.14 | $5.39 | +42.59% |
Jan 2026 | $2.75 | $3.78 | +37.45% |
Dec 2025 | $2.29 | $2.75 | +16.53% |
Nov 2025 | $2.75 | $2.36 | -13.55% |